等待开盘 10-12 09:30:00 美东时间
+2.380
+3.89%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从49美元升至50美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从24美元升至25美元
10-02 08:33
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Citigroup raised the price target for Hewlett Packard Enterprise Company (NYSE:HPE) from $76 to $92. Citigroup...
10-02 02:10
今日重点评级关注:Canaccord Genuity:维持Aurora Innovation"买入"评级,目标价从15美元升至17美元;摩根大通:维持皇家加勒比邮轮"超配"评级,目标价从345美元升至394美元
09-25 15:55
Oppenheimer analyst Ittai Kidron maintains Dynatrace (NYSE:DT) with a Outperform and raises the price target from $60 to $71.
09-25 01:18
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst David George upgraded Regions Financial Corp (NYSE:RF) from Underperform to Neutral...
09-18 20:49
今日重点评级关注:HC Wainwright & Co.:上调Cardiff Oncology评级至"买入",目标价9美元;古根海姆:维持Inventiva"买入"评级,目标价从11美元升至14美元
09-16 16:10
今日重点评级关注:Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从10美元升至10.5美元;摩根士丹利:维持Aurora Innovation"超配"评级,目标价从14美元升至18美元
09-14 16:05
Wedbush analyst Steven Wahrhaftig assumes Dynatrace (NYSE:DT) with a Neutral rating and announces Price Target of $54.
09-11 20:55
8月CPI符合预期,美联储下周加息概率拉升至90%;油价重挫逾3%,伊朗与海湾六国下周会晤;绩优股甲骨文盘前涨逾7%,Adobe跌近4%;SpaceX再签天价算力单>>
09-11 20:42